↓ Skip to main content

Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway

Overview of attention for article published in Journal of Translational Medicine, November 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

patent
3 patents

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway
Published in
Journal of Translational Medicine, November 2011
DOI 10.1186/1479-5876-9-192
Pubmed ID
Authors

Veerauo V Konkankit, Won Kim, Richard C Koya, Ascia Eskin, Mai-Anh Dam, Stanley Nelson, Antoni Ribas, Linda M Liau, Robert M Prins

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 51 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 23%
Student > Ph. D. Student 6 12%
Student > Doctoral Student 5 10%
Other 4 8%
Professor > Associate Professor 4 8%
Other 11 21%
Unknown 10 19%
Readers by discipline Count As %
Medicine and Dentistry 18 35%
Biochemistry, Genetics and Molecular Biology 9 17%
Immunology and Microbiology 6 12%
Agricultural and Biological Sciences 4 8%
Computer Science 1 2%
Other 3 6%
Unknown 11 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 June 2021.
All research outputs
#4,711,393
of 22,854,458 outputs
Outputs from Journal of Translational Medicine
#770
of 4,000 outputs
Outputs of similar age
#28,062
of 142,567 outputs
Outputs of similar age from Journal of Translational Medicine
#12
of 53 outputs
Altmetric has tracked 22,854,458 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,000 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 142,567 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.